首页> 外文期刊>Clinical and Experimental Metastasis >An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2−/− γc−/− mouse
【24h】

An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2−/− γc−/− mouse

机译:使用MTLn3细胞和Rag2 -// γc-// 小鼠研究肿瘤细胞自主转移程序的改进模型

获取原文
获取原文并翻译 | 示例
           

摘要

The occurrence of metastases is a critical determinant of the prognosis for breast cancer patients. Effective treatment of breast cancer metastases is hampered by a poor understanding of the mechanisms involved in the formation of these secondary tumor deposits. To study the processes of metastasis, valid in vivo tumor metastasis models are required. Here, we show that increased expression of the EGF receptor in the MTLn3 rat mammary tumor cell-line is essential for efficient lung metastasis formation in the Rag mouse model. EGFR expression resulted in delayed orthotopic tumor growth but at the same time strongly enhanced intravasation and lung metastasis. Previously, we demonstrated the critical role of NK cells in a lung metastasis model using MTLn3 cells in syngenic F344 rats. However, this model is incompatible with human EGFR. Using the highly metastatic EGFR-overexpressing MTLn3 cell-line, we report that only Rag2−/−γc−/− mice, which lack NK cells, allow efficient lung metastasis from primary tumors in the mammary gland. In contrast, in nude and SCID mice, the remaining innate immune cells reduce MTLn3 lung metastasis formation. Furthermore, we confirm this finding with the orthotopic transplantation of the 4T1 mouse mammary tumor cell-line. Thus, we have established an improved in vivo model using a Rag2−/− γc−/− mouse strain together with MTLn3 cells that have increased levels of the EGF receptor, which enables us to study EGFR-dependent tumor cell autonomous mechanisms underlying lung metastasis formation. This improved model can be used for drug target validation and development of new therapeutic strategies against breast cancer metastasis formation.
机译:转移的发生是乳腺癌患者预后的关键决定因素。对乳腺癌转移的有效治疗因对这些继发性肿瘤沉积物形成机制的了解不足而受到阻碍。为了研究转移的过程,需要有效的体内肿瘤转移模型。在这里,我们显示MTLn3大鼠乳腺肿瘤细胞系中EGF受体的表达增加对于Rag小鼠模型中有效的肺转移形成至关重要。表皮生长因子受体表达导致原位肿瘤生长延迟,但同时强烈增强了血管内侵袭和肺转移。以前,我们在同基因F344大鼠中使用MTLn3细胞证明了NK细胞在肺转移模型中的关键作用。然而,该模型与人EGFR不相容。使用高度转移性的EGFR过表达的MTLn3细胞系,我们报道只有缺少NK细胞的Rag2 -/-γc-/-小鼠允许有效的肺转移乳腺中的原发性肿瘤。相反,在裸鼠和SCID小鼠中,剩余的先天免疫细胞减少了MTLn3肺转移的形成。此外,我们通过4T1小鼠乳腺肿瘤细胞系的原位移植证实了这一发现。因此,我们使用Rag2 -/-γc-/-小鼠品系以及ETL受体水平升高的MTLn3细胞建立了改良的体内模型。使我们能够研究肺转移形成基础的EGFR依赖性肿瘤细胞自主机制。该改进的模型可用于药物靶标验证和开发针对乳腺癌转移形成的新治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号